epigenome 1. 2 background: gwas genome-wide association studies 3

49
Epigenome 1

Upload: elijah-fox

Post on 26-Dec-2015

221 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

1

Epigenome

Page 2: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

2

Page 3: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

3

Background: GWAS

Genome-Wide Association Studies

Page 4: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

4

What is a genome-wide association study?It involves rapidly looking at markers across the complete sets of DNA, or genomes, of many people to find genetic variations associated with a particular disease. Researchers can use the information to develop better ways to detect, treat and prevent the disease. GWAS are useful in finding genetic variations that contribute to common, complex diseases, such as asthma, cancer, diabetes, heart disease and mental illnesses.

Page 5: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

5

• A Catalog of Published Genome-Wide Association Studies• http://www.genome.gov/gwastudies/

Page 6: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

6

Why are such studies possible now?- completion of the Human Genome Project in

2003 - International HapMap Project in 2005- tools include

- computerized databases that contain the reference human genome sequence,

- a map of human genetic variation and - a set of new technologies that can quickly and

accurately analyze whole-genome samples for genetic variations that contribute to the onset of a disease.

Page 7: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

7

How will genome-wide association studies benefit human health?- Leads to personalized medicine.- provide patients with individualized

information about their risks of developing certain diseases.

- design prevention programs to each person's unique genetic makeup.

- select the treatments most likely to be effective and least likely to cause adverse reactions in that particular patient.

Page 8: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

8

What have genome-wide association studies found?- 2005, 3 studies found that age-related macular

degeneration (a common form of blindness) is associated with variation in the gene for complement factor H, which produces a protein involved in regulating inflammation.

- Found genetic variations that contribute to risk of type 2 diabetes, Parkinson's disease, heart disorders, obesity, Crohn's disease and prostate cancer, as well as genetic variations that influence response to anti-depressant medications.

Page 9: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

9

How are genome-wide association studies conducted?- use two groups of participants: people with the disease

being studied and similar people without the disease. - Get DNA from each participant, eg blood sample or

mouth cells.- complete set of DNA, or genome, is:

- purified from the blood or cells, - placed on tiny chips and - scanned on automated laboratory machines. - single nucleotide polymorphisms, or SNPs, are found.

- genetic variations significantly more frequent in people with the disease compared to people without disease, are said to be "associated" with the disease.

Page 10: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

10

Associated genetic variations can point to the region of the human genome where the disease-causing problem is.Associated variants may not directly cause the disease. They may just be connected with the actual causal variants. Additional steps, such as sequencing DNA base pairs in that particular region of the genome, identify the exact genetic change involved in the disease.

Page 11: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

11

Page 12: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

12

Page 13: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

13

Histone modification patterns denote complex chromatin states

Page 14: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

14

Page 15: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

15

Page 16: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

16

Page 17: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

17

A vast resource for the normal epigenome ~3,000 data sets from over 400 cellular states (cell types, differentiation states, developmental time points) ~80 highly information rich ‘complete epigenomes’ with multiple data types per cell/tissue state

DNaseI 6-30 histone modifications DNA methylation RNA

Page 18: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

18

Page 19: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

19

Most epigenome features are highly cell-selective

Page 20: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

20

Most epigenomic features are highly cell-and lineage-selective

Page 21: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

21

Page 22: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

22

Connecting epigenomic data to genes

Page 23: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

23

Page 24: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

24

The epigenome can ‘remember’ earlier cellular states.

Page 25: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

25

Developmental persistence of enhancer chromatin accessibility

Page 26: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

26

Regulatory DNA variation associated with common diseases and traits

Page 27: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

27

Identification of disease-and trait-associated variation by GWAS

GWAS disease/trait associated variants x Maps of regulatory DNA in >300 diverse cell and tissue types

Maurano et al., Science 2012

Page 28: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

28

Disease-associated variation is concentrated in non-coding regulatory DNA.Disease-and trait-associated SNPs are concentrated in regulatory DNA

Page 29: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

29

GWAS variants selectively localize in regulatory DNA of pathologically relevant cell types

Page 30: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

30

Disease-associated variation clusters in pathogenic or target cell types

Maurano et al., Science 2012

Page 31: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

31

Variants associated with diseases and traits with developmental contributions preferentially localize in fetal regulatory DNA.

Page 32: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

32

Surveying the normal epigenomic landscape Developing cells and tissues

Page 33: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

33

Most variants lie in regulatory DNA of fetal origin

Maurano et al., Science 2012

Page 34: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

34

Fetal regulatory variants are enriched in traits & diseases with known links to intrauterine exposures

Maurano et al., Science 2012

Page 35: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

35

Correcting genetic variation for epigenetic circuitry Regulatory DNA with disease-associated variants mainly controls distant genes

Page 36: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

36

Page 37: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

37

Page 38: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

38

Regulatory GWAS variants linked to distant genes with pathogenic potential

Page 39: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

39

Disease-associated variants selectively localize to relevant transcription factor recognition sites

Page 40: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

40

Within regulatory DNA, disease-associated variants systematically localize within relevant TF recognition sites

Page 41: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

41

Page 42: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

42

Page 43: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

43

Disease-associated variants cluster in regulatory pathways and form regulatory networks

Page 44: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

44

Page 45: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

45

Page 46: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

46

Page 47: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

47

Epigenomic data enable pinpointing of disease/trait-relevant cell types

Page 48: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

48

Summary & Implications The Roadmap Epigenomics Project has created a vast, high-quality atlas of the epigenomic states of normal cells and tissues

A powerful, enabling resource for diverse investigators Roadmap data can be integrated to reveal important insights into cellular phenotypes and functions

Many novel features of the data await exploration and discovery Disease-associated variation is concentrated in regulatory DNA

Enables a coherent approach to understanding the role of non-coding variants Reference maps of normal cells enable pathogenic insights Reference maps are a powerful tool that, when combined with genetic data, may obviate the need to perform deep profiling of disease populations Although it has covered significant ground, the Roadmap is only a start

Only a fraction of the true diversity of human cell types and states has been covered

Page 49: Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3

49

Thank you.